spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

WADA to ban non-diagnostic use of carbon monoxide

The World Anti-Doping Agency (WADA) will add the non-diagnostic use of carbon monoxide to its prohibited methods list from next year, the organisation said.

The gas is used in low doses to help measure critical blood metrics in athletes, especially haemoglobin levels, but there have been suggestions that repeated inhalation can be used to improve athletic performance.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The International Cycling Union (UCI) has banned the use of carbon monoxide outside of a medical facility, and in a press release on Wednesday WADA said its use could increase erythropoiesis – the process of creating new red blood cells.

“The use of carbon monoxide for diagnostic purposes, such as total haemoglobin mass measurements or the determination of pulmonary diffusion capacity, is not prohibited,” WADA added.

“The current wording was chosen to differentiate between illicit use and the intake resulting from natural combustion processes (e.g. smoking), the environment (e.g. exhaust gases) or diagnostic procedures.”

An investigation published by website Escape Collective during this year’s Tour de France alleged several teams used carbon monoxide rebreather devices to optimise altitude training.

Hot this week

UAE activates new mechanism to strengthen drug supply security

The mechanism seeks to address monopolistic dynamics that can...

Oman’s Health Ministry budget nears RO1 bln; over 20 new projects planned

MOH says over 20 new health projects planned, including...

Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs

Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex...

K-beauty ranks No. 1 in Japan’s imported cosmetics market for 4 consecutive years

K-beauty claimed the top spot in Japan’s imported cosmetics...

KFSH Successfully Implements Advanced Technology to Treat Prostate Cancer

King Faisal Specialist Hospital and Research Centre (KFSH) in...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img